[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-378855-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-378855-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","covid-19-as-a-catalyst-for-reimagining-cervical-cancer-prevention","COVID-19 as a catalyst for reimagining cervical cancer prevention","","Cervical cancer caused millions of deaths over the past decade, prompting the World Health Organization’s 2019 Cervical Cancer Elimination Strategy targeting vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress, but pandemic lessons—particularly vaccination approaches, self-administered testing, and globally coordinated mobilization—can support achievement of the strategy’s goals. The authors also address failures to ensure adequate representation of global voices and stress that elimination efforts must include the most affected countries from the earliest planning stage.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/covid-19-as-a-catalyst-for-reimagining-cervical-cancer-prevention/378855/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/covid-19-as-a-catalyst-for-reimagining-cervical-cancer-prevention/378855.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-24",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the Cervical Cancer Elimination Strategy launched in 2019?","Question",{"text":63,"@type":64},"It aims to reduce cervical cancer incidence from about 15 per 100,000 women to less than 4 per 100,000 by 2030 through vaccination, screening, and treatment targets.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the COVID-19 pandemic affect progress on cervical cancer elimination?",{"text":68,"@type":64},"Progress on vaccination, screening, and treatment was disrupted shortly after the strategy’s launch, requiring lessons learned during the pandemic to be applied to cervical cancer efforts.",{"name":70,"@type":61,"acceptedAnswer":71},"What pandemic lessons does the article highlight as helpful for prevention?",{"text":72,"@type":64},"The article emphasizes lessons related to vaccination, self-administered testing, and coordinated mobilization on a global scale to accelerate progress toward elimination targets.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},378855,1790342564,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","FEATURE ARTICLE  \nPOINT OF VIEW  \nCOVID-19 as a catalyst for reimagining cervical cancer prevention  \nAbstract Cervical cancer has killed millions of women over the past decade. In 2019 the World Health Organization launched the Cervical Cancer Elimination Strategy, which included ambitious targets for vaccination, screening, and treatment. The COVID-19 pandemic disrupted progress on the strategy, but lessons learned during the pandemic – especially in vaccination, self-administered testing, and coordinated mobilization on a global scale – may help with efforts to achieve its targets. However, we must also learn from the failure of the COVID-19 response to include adequate representation of global voices. Efforts to eliminate cervical cancer will only succeed if those countries most affected are involved from the very start of planning. In this article we summarize innovations and highlight missed opportunities in the COVID response, and make recommendations to leverage the COVID experience to accelerate the elimination of cervical cancer globally.  \nREBECCA LUCKETT*, SARAH FELDMAN, YIN LING WOO,  \nANNA-BARBARA MOSCICKI, ANNA R GIULIANO, SILVIA DE SANJOSÉ, ANDREAS M KAUFMANN, SHUK ON ANNIE LEUNG, FRANCISCO GARCIA, KAREN CHAN, NEERJA BHATLA, MARGARET STANLEY, JULIA BROTHERTON, JOEL PALEFSKY, SUZANNE GARLAND, ON BEHALF OF THE INTERNATIONAL PAPILLOMAVIRUS SOCIETY (IPVS) POLICY COMMITTEE  \n*For correspondence:  \n[rluckett@bidmc.harvard.edu](rluckett@bidmc.harvard.edu)[ ](rluckett@bidmc.harvard.edu)[Competing interest:](Competing interest: See page 8)[ See page 8](Competing interest: See page 8)  \n[Funding:](Funding: See page 9)[ See page 9](Funding: See page 9)  \nReviewing Editor: Peter Rodgers, eLife, United Kingdom  This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built  \nupon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nIntroduction  \nCervical cancer is the fourth most common cancer in women (after breast, colorectal and lung cancer), and resulted in 311, 000 deaths in 2018 (Arbyn et al., 2020) . The burden of cervical cancer also continues to rise – despite being a preventable disease – and this burden falls disproportionately on women in low-and middleincome countries (LMICs) (Cohen et al., 2019; Zhang et al., 2021) . Many countries also lack the resources to treat cervical cancer, resulting in unnecessary death and suffering (Union for International Cancer Control, 2023) . Moreover, cervical cancer is most often diagnosed in relatively young women who are often the primary wage earners in their household (Zhang et al., 2021; American Society of Clinical Oncology, 2023; Reed et al., 2000) .  \nThe goal of the Cervical Cancer Elimination Strategy, launched by the World Health Organization in 2019, is to reduce incidence of cervical cancer from about 15 per 100,000 women to  \nless than 4 per 100,000 by the year 2030 (World Health Organization, 2020) . The strategy has identified three targets to help it reach this goal: to provide HPV vaccination to 90% of girls by age 15; offer 70% women cervical screening with a high precision assay at least twice (by age 35, and again by age 45); and to treat 90% of women with pre-cancer and manage 90% of women with invasive cancer. HPV vaccination will likely have the biggest impact on the incidence of cervical cancer in the long run, with screening and treatment having bigger impacts in the short-term.  \nUnfortunately, progress on vaccination, screening and treatment was disrupted shortly after launch by the COVID-19 pandemic. In this article, on behalf of the Policy Committee of the International Papillomavirus Society (IPVS), we summarize the impact of the pandemic on efforts to eliminate cervical cancer and discuss how lessons learned during the pandemic can be applied to a different global public health threat – cervical ca","cbCaisviggTxS66E","https://ap.wps.com/l/cbCaisviggTxS66E","pdf",1936864,12,"English","# Introduction\n## Cervical cancer burden and prevention goals\n## How COVID-19 disrupted elimination progress\n## Cervical cancer prevention before the COVID-19 pandemic","[{\"question\":\"What is the main goal of the Cervical Cancer Elimination Strategy launched in 2019?\",\"answer\":\"It aims to reduce cervical cancer incidence from about 15 per 100,000 women to less than 4 per 100,000 by 2030 through vaccination, screening, and treatment targets.\"},{\"question\":\"How did the COVID-19 pandemic affect progress on cervical cancer elimination?\",\"answer\":\"Progress on vaccination, screening, and treatment was disrupted shortly after the strategy’s launch, requiring lessons learned during the pandemic to be applied to cervical cancer efforts.\"},{\"question\":\"What pandemic lessons does the article highlight as helpful for prevention?\",\"answer\":\"The article emphasizes lessons related to vaccination, self-administered testing, and coordinated mobilization on a global scale to accelerate progress toward elimination targets.\"}]","COVID-19 as a catalyst for reimagining cervical cancer prevention | PDF",1790232847]